such as pain and photophobia, reappearance of corneal ulcers in grafts, and aggravated edema of the corneal graft bed. Corneal transparency, corneal edema degree, and corneal neovascularization were ...

It’s best to discuss your risks with your doctor. In the case of mouth ulcers, a topical anesthetic such as lidocaine may help numb the pain. If you receive a topical anesthetic, it’s likely ...

A peptic ulcer is a sore that forms when digestive juices wear away the lining of the digestive system. It may occur in the lining of the stomach or duodenum. A peptic ulcer can affect several ...

The most concerning is Acanthamoeba keratitis, a rare but potentially vision-threatening infection that can cause severe pain, corneal ulcers and even blindness.” Bacteria like Pseudomonas aeruginosa ...

Urcosimod is currently being evaluated in a phase 2 trial evaluating it's efficacy and safety in adults with neuropathic corneal pain. OKYO Pharma has filed a Fast Track designation application with ...

A vast range of CBD products, including oils, tinctures, and balms, may help people experiencing physical pain. This article discusses how CBD products may help relieve pain. It also provides a ...

LONDON and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic ...

LONDON and NEW YORK, March 10, 2025), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an ...

OKYO Pharma Limited has filed for Fast Track designation with the U.S. FDA for its drug urcosimod, aimed at treating neuropathic corneal pain, a painful eye condition currently lacking an FDA ...

Jacob, Ph.D., Chief Executive Officer of OKYO Pharma. “Notably, neuropathic corneal pain falls into this category, and our application for Fast Track designation marks a significant milestone ...